Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Vogelzang

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|March 31, 1983
Hypertension after metoclopramideN J Vogelzang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma?N J Vogelzang
Seminars in Oncology|August 1, 1992
Malignant mesothelioma: diagnostic and management strategies for 1992N J Vogelzang
The Journal of Urology|June 1, 1990
Cisplatin and etoposide for metastatic testis cancer in a renal transplant recipientN J Vogelzang
Seminars in Oncology|December 22, 1999
Docetaxel (Taxotere) in hormone-refractory prostate cancer: a new addition to the physicians' toolbagN J Vogelzang
The Journal of Urology|September 24, 1999
Re: Radiation induced renal cell cancer: a report of 4 cases and review of the literatureN J Vogelzang
Cancer|June 15, 1992
Cisplatin-based chemotherapy in a renal transplant recipientN J Vogelzang
Cancer Treatment Reports|November 1, 1979
"Adriamycin flare": a skin reaction resembling extravasationN J Vogelzang
Annals of Internal Medicine|December 1, 1982
Extragonadal germ-cell tumorsN J Vogelzang
Oncology (Williston Park, N.Y.)|October 1, 1991
Nephrotoxicity from chemotherapy: prevention and managementN J Vogelzang
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|March 31, 1983
Hypertension after metoclopramideN J Vogelzang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma?N J Vogelzang
Seminars in Oncology|August 1, 1992
Malignant mesothelioma: diagnostic and management strategies for 1992N J Vogelzang
The Journal of Urology|June 1, 1990
Cisplatin and etoposide for metastatic testis cancer in a renal transplant recipientN J Vogelzang
Seminars in Oncology|December 22, 1999
Docetaxel (Taxotere) in hormone-refractory prostate cancer: a new addition to the physicians' toolbagN J Vogelzang
The Journal of Urology|September 24, 1999
Re: Radiation induced renal cell cancer: a report of 4 cases and review of the literatureN J Vogelzang
Cancer|June 15, 1992
Cisplatin-based chemotherapy in a renal transplant recipientN J Vogelzang
Cancer Treatment Reports|November 1, 1979
"Adriamycin flare": a skin reaction resembling extravasationN J Vogelzang
Annals of Internal Medicine|December 1, 1982
Extragonadal germ-cell tumorsN J Vogelzang
Oncology (Williston Park, N.Y.)|October 1, 1991
Nephrotoxicity from chemotherapy: prevention and managementN J Vogelzang
Pageof 25